Bernstein Upgrades AmerisourceBergen (ABC) to Market Perform
More News related to ABC
- AmerisourceBergen to Help Hospitals Achieve 'Meaningful Use'
- AmerisourceBergen Approves Quarterly Dividend
- MicroStrategy Recognizes Five Companies for Excellence in Enterprise-Class Business Intelligence
- AmerisourceBergen (ABC) Posts Q4 EPS of $0.52, Beats by 8c; Guides FY10 EPS
- AmerisourceBergen Reports Record $0.52 in Diluted EPS, a 44 Percent Increase, and Record Revenue of $19.3 Billion for the December Quarter
More News related to Upgrades
- FBR Research Upgrades Gaylord Entertainment (GET) to Outperform
- BofA/Merrill Lynch Upgraded Dell (DELL) to Buy
- Soleil Securities Upgrades Zebra Technologies (ZBRA) to Gradually Accumulate; Valuation Call
- UBS Issues Intraday Upgrade on Cimarex Energy (XEC)
- Boenning & Scattergood Upgrades Equinix (EQIX) to Outperform
Bernstein upgrades AmerisourceBergen (NYSE: ABC) from Underperform to Market Perform.
To see all the upgrades/downgrades on shares of ABC, visit our Analyst Ratings page.
AmerisourceBergen Corporation (AmerisourceBergen) is a pharmaceutical services company, with operations in the United States, Canada and the United Kingdom.
Related Categories
UpgradesStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
